Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Capital Expenditures (2024 - 2025)

Connect Biopharma Holdings' Capital Expenditures history spans 2 years, with the latest figure at $34000.0 for Q3 2025.

  • For Q3 2025, Capital Expenditures fell 76.87% year-over-year to $34000.0; the TTM value through Sep 2025 reached $731000.0, changed N/A, while the annual FY2024 figure was $750000.0, 825.93% up from the prior year.
  • Capital Expenditures for Q3 2025 was $34000.0 at Connect Biopharma Holdings, down from $303000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $313000.0 in Q4 2024 and bottomed at $34000.0 in Q3 2025.